RE: Science and business9 Dec 2022 13:15
" For the latter, the company does seem to be lacking in how to manage investor relations and the wider pharmaceutical world."
This has been beaten to death but STILL they don't seem to have grasped the facts or haven't the least intention of changing. I hope, sincerely, I am totally wrong on the latter because such a stance in company management can be fatal.